Click here for mobile version: http://www.healthexecwire.com/releases/hew013113.htm
selected news releases for today's health care executives
With the aim to quantify some of the most valuable disruptive ideas in pharma, we’ve collected a C-level industry advisory. In the lead up to our Philadelphia conference, we held two closed door meetings in which they brainstormed how disruptive ideas might change the industry. Click here to see which disruptive ideas will affect your bottom line in 2013. Some key Pharma disruptions include…
Best, Theo Fellgett eyeforpharma theo@eyeforpharma.com |
Return to HealthExecWire Archive Menu